
# Title 21— FOOD AND DRUGS
### CHAPTER 9— FEDERAL FOOD, DRUG, AND COSMETIC ACT
#### § 331. Prohibited acts
###### (ll) The introduction or delivery for introduction into interstate commerce of any food to which has been added a drug approved under section 355 of this title , a biological product licensed under section 262 of title 42 , or a drug or a biological product for which substantial clinical investigations have been instituted and for which the existence of such investigations has been made public, unless

(1) such drug or such biological product was marketed in food before any approval of the drug under section 355 of this title , before licensure of the biological product under such section 262 of title 42 , and before any substantial clinical investigations involving the drug or the biological product have been instituted;

(2) the Secretary, in the Secretary’s discretion, has issued a regulation, after notice and comment, approving the use of such drug or such biological product in the food;

(3) the use of the drug or the biological product in the food is to enhance the safety of the food to which the drug or the biological product is added or applied and not to have independent biological or therapeutic effects on humans, and the use is in conformity with

(A) a regulation issued under section 348 of this title prescribing conditions of safe use in food;

(B) a regulation listing or affirming conditions under which the use of the drug or the biological product in food is generally recognized as safe;

(C) the conditions of use identified in a notification to the Secretary of a claim of exemption from the premarket approval requirements for food additives based on the notifier’s determination that the use of the drug or the biological product in food is generally recognized as safe, provided that the Secretary has not questioned the general recognition of safety determination in a letter to the notifier;

(D) a food contact substance notification that is effective under section 348(h) of this title ; or

(E) such drug or biological product had been marketed for smoking cessation prior to September 27, 2007 ; or

(4) the drug is a new animal drug whose use is not unsafe under section 360b of this title .

(mm) The failure to submit a report or provide a notification required under section 350f(d) of this title .

(nn) The falsification of a report or notification required under section 350f(d) of this title .

(oo) The sale of tobacco products in violation of a no-tobacco-sale order issued under section 333(f) of this title .

(pp) The introduction or delivery for introduction into interstate commerce of a tobacco product in violation of section 387k of this title .

(qq)

(1) Forging, counterfeiting, simulating, or falsely representing, or without proper authority using any mark, stamp (including tax stamp), tag, label, or other identification device upon any tobacco product or container or labeling thereof so as to render such tobacco product a counterfeit tobacco product.

(2) Making, selling, disposing of, or keeping in possession, control, or custody, or concealing any punch, die, plate, stone, or other item that is designed to print, imprint, or reproduce the trademark, trade name, or other identifying mark, imprint, or device of another or any likeness of any of the foregoing upon any tobacco product or container or labeling thereof so as to render such tobacco product a counterfeit tobacco product.

(3) The doing of any act that causes a tobacco product to be a counterfeit tobacco product, or the sale or dispensing, or the holding for sale or dispensing, of a counterfeit tobacco product.

(rr) The charitable distribution of tobacco products.

(ss) The failure of a manufacturer or distributor to notify the Attorney General and the Secretary of the Treasury of their knowledge of tobacco products used in illicit trade.
